SCLERAL THINNING

SCLERAL THINNING was reported 106 times

SCLERAL THINNING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 alpha-1 Adrenergic Agonist [EPC] 1 0.0002
1 Alkylating Drug [EPC] 29 0.0001
2 Vitamin K [EPC] 1 0.0001
3 Quinolone Antimicrobial [EPC] 1 0.0001
4 Soluble Guanylate Cyclase Stimulator [EPC] 3 0.0001
5 Vascular Endothelial Growth Factor Inhibitor [EPC] 12 0.0001
6 Anticholinergic [EPC] 1 0.0001
7 Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] 1 0.0001
8 Human Immunoglobulin G [EPC] 1 0.0000
9 Aminoglycoside Antibacterial [EPC] 2 0.0000
10 Prostaglandin Analog [EPC] 3 0.0000
11 Antirheumatic Agent [EPC] 3 0.0000
12 Tetracycline-class Drug [EPC] 2 0.0000
13 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
14 Corticosteroid [EPC] 30 0.0000
15 Prostacycline Vasodilator [EPC] 3 0.0000
16 beta3-Adrenergic Agonist [EPC] 1 0.0000
17 Macrolide Antimicrobial [EPC] 1 0.0000
18 Fluoroquinolone Antibacterial [EPC] 2 0.0000
19 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
20 Expectorant [EPC] 3 0.0000
21 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
22 Tumor Necrosis Factor Blocker [EPC] 11 0.0000
23 Purine Antimetabolite [EPC] 1 0.0000
24 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
25 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
26 Vitamin C [EPC] 3 0.0000
27 Vitamin D [EPC] 2 0.0000
28 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
29 Vitamin B12 [EPC] 2 0.0000
30 Platelet Aggregation Inhibitor [EPC] 2 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
32 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000